Eintrag weiter verarbeiten
Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR
Gespeichert in:
Zeitschriftentitel: | International Journal of Laboratory Hematology |
---|---|
Personen und Körperschaften: | , , , , , , , , |
In: | International Journal of Laboratory Hematology, 39, 2017, 2, S. 175-184 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Wiley
|
Schlagwörter: |
author_facet |
Zheng, Z. Zhang, P. He, G. Liao, K. Wang, Z. Pan, J. Du, K. Du, J. Li, B.‐A. Zheng, Z. Zhang, P. He, G. Liao, K. Wang, Z. Pan, J. Du, K. Du, J. Li, B.‐A. |
---|---|
author |
Zheng, Z. Zhang, P. He, G. Liao, K. Wang, Z. Pan, J. Du, K. Du, J. Li, B.‐A. |
spellingShingle |
Zheng, Z. Zhang, P. He, G. Liao, K. Wang, Z. Pan, J. Du, K. Du, J. Li, B.‐A. International Journal of Laboratory Hematology Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR Biochemistry (medical) Clinical Biochemistry Hematology General Medicine |
author_sort |
zheng, z. |
spelling |
Zheng, Z. Zhang, P. He, G. Liao, K. Wang, Z. Pan, J. Du, K. Du, J. Li, B.‐A. 1751-5521 1751-553X Wiley Biochemistry (medical) Clinical Biochemistry Hematology General Medicine http://dx.doi.org/10.1111/ijlh.12600 <jats:title>Summary</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Detection of recurrent genetic abnormalities is of great significance for a refined diagnosis and assessment of prognosis in leukemia. Conventional nested reverse transcription <jats:styled-content style="fixed-case">PCR</jats:styled-content> is labor intensive and time‐consuming.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We have developed a novel dual‐color TaqMan probe‐based real‐time <jats:styled-content style="fixed-case">PCR</jats:styled-content> method for the simultaneous screening of 45 fusion transcripts in 12 parallel reactions. The method was tested and validated with cell lines carrying known fusion transcripts and patient samples.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A multiplex real‐time <jats:styled-content style="fixed-case">PCR</jats:styled-content> method was successfully developed for rapid detection of 45 fusion genes and validated for 15 of the more commonly detected fusion genes. Intra‐assay reproducibility assessed for the most frequent rearrangements ranged from 0.41% to 0.74% for the coefficient of variation (<jats:styled-content style="fixed-case">CV</jats:styled-content>) of cycle threshold (Ct) and the interassay reproducibility ranged from 1.62% to 2.83% in five separate experiments. The lowest detection limit for the translocations tested ranged between 1 : 16 000 and 1 : 32 000. Validation of the method with 213 patient samples showed 100% specificity and excellent consistence with conventional nested <jats:styled-content style="fixed-case">RT</jats:styled-content>‐<jats:styled-content style="fixed-case">PCR</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Overall, we believe that this method is easily applicable, cost‐effective, and clinically useful for a rapid screening of fusion genes in the initial diagnostic phase of leukemia. Its use can also be extended to the monitoring of minimal residual disease.</jats:p></jats:sec> Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time <scp>PCR</scp> International Journal of Laboratory Hematology |
doi_str_mv |
10.1111/ijlh.12600 |
facet_avail |
Online |
finc_class_facet |
Medizin Biologie Chemie und Pharmazie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9pamxoLjEyNjAw |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9pamxoLjEyNjAw |
institution |
DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
imprint |
Wiley, 2017 |
imprint_str_mv |
Wiley, 2017 |
issn |
1751-5521 1751-553X |
issn_str_mv |
1751-5521 1751-553X |
language |
English |
mega_collection |
Wiley (CrossRef) |
match_str |
zheng2017simultaneousdetectionof45fusiongenesinleukemiabydualcolorfluorescencerealtimepcr |
publishDateSort |
2017 |
publisher |
Wiley |
recordtype |
ai |
record_format |
ai |
series |
International Journal of Laboratory Hematology |
source_id |
49 |
title |
Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_unstemmed |
Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_full |
Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_fullStr |
Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_full_unstemmed |
Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_short |
Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_sort |
simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time <scp>pcr</scp> |
topic |
Biochemistry (medical) Clinical Biochemistry Hematology General Medicine |
url |
http://dx.doi.org/10.1111/ijlh.12600 |
publishDate |
2017 |
physical |
175-184 |
description |
<jats:title>Summary</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Detection of recurrent genetic abnormalities is of great significance for a refined diagnosis and assessment of prognosis in leukemia. Conventional nested reverse transcription <jats:styled-content style="fixed-case">PCR</jats:styled-content> is labor intensive and time‐consuming.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We have developed a novel dual‐color TaqMan probe‐based real‐time <jats:styled-content style="fixed-case">PCR</jats:styled-content> method for the simultaneous screening of 45 fusion transcripts in 12 parallel reactions. The method was tested and validated with cell lines carrying known fusion transcripts and patient samples.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A multiplex real‐time <jats:styled-content style="fixed-case">PCR</jats:styled-content> method was successfully developed for rapid detection of 45 fusion genes and validated for 15 of the more commonly detected fusion genes. Intra‐assay reproducibility assessed for the most frequent rearrangements ranged from 0.41% to 0.74% for the coefficient of variation (<jats:styled-content style="fixed-case">CV</jats:styled-content>) of cycle threshold (Ct) and the interassay reproducibility ranged from 1.62% to 2.83% in five separate experiments. The lowest detection limit for the translocations tested ranged between 1 : 16 000 and 1 : 32 000. Validation of the method with 213 patient samples showed 100% specificity and excellent consistence with conventional nested <jats:styled-content style="fixed-case">RT</jats:styled-content>‐<jats:styled-content style="fixed-case">PCR</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Overall, we believe that this method is easily applicable, cost‐effective, and clinically useful for a rapid screening of fusion genes in the initial diagnostic phase of leukemia. Its use can also be extended to the monitoring of minimal residual disease.</jats:p></jats:sec> |
container_issue |
2 |
container_start_page |
175 |
container_title |
International Journal of Laboratory Hematology |
container_volume |
39 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792334524656386056 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T14:30:01.545Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Simultaneous+detection+of+45+fusion+genes+in+leukemia+by+dual%E2%80%90color+fluorescence+real%E2%80%90time+PCR&rft.date=2017-04-01&genre=article&issn=1751-553X&volume=39&issue=2&spage=175&epage=184&pages=175-184&jtitle=International+Journal+of+Laboratory+Hematology&atitle=Simultaneous+detection+of+45+fusion+genes+in+leukemia+by+dual%E2%80%90color+fluorescence+real%E2%80%90time+%3Cscp%3EPCR%3C%2Fscp%3E&aulast=Li&aufirst=B.%E2%80%90A.&rft_id=info%3Adoi%2F10.1111%2Fijlh.12600&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792334524656386056 |
author | Zheng, Z., Zhang, P., He, G., Liao, K., Wang, Z., Pan, J., Du, K., Du, J., Li, B.‐A. |
author_facet | Zheng, Z., Zhang, P., He, G., Liao, K., Wang, Z., Pan, J., Du, K., Du, J., Li, B.‐A., Zheng, Z., Zhang, P., He, G., Liao, K., Wang, Z., Pan, J., Du, K., Du, J., Li, B.‐A. |
author_sort | zheng, z. |
container_issue | 2 |
container_start_page | 175 |
container_title | International Journal of Laboratory Hematology |
container_volume | 39 |
description | <jats:title>Summary</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Detection of recurrent genetic abnormalities is of great significance for a refined diagnosis and assessment of prognosis in leukemia. Conventional nested reverse transcription <jats:styled-content style="fixed-case">PCR</jats:styled-content> is labor intensive and time‐consuming.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We have developed a novel dual‐color TaqMan probe‐based real‐time <jats:styled-content style="fixed-case">PCR</jats:styled-content> method for the simultaneous screening of 45 fusion transcripts in 12 parallel reactions. The method was tested and validated with cell lines carrying known fusion transcripts and patient samples.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A multiplex real‐time <jats:styled-content style="fixed-case">PCR</jats:styled-content> method was successfully developed for rapid detection of 45 fusion genes and validated for 15 of the more commonly detected fusion genes. Intra‐assay reproducibility assessed for the most frequent rearrangements ranged from 0.41% to 0.74% for the coefficient of variation (<jats:styled-content style="fixed-case">CV</jats:styled-content>) of cycle threshold (Ct) and the interassay reproducibility ranged from 1.62% to 2.83% in five separate experiments. The lowest detection limit for the translocations tested ranged between 1 : 16 000 and 1 : 32 000. Validation of the method with 213 patient samples showed 100% specificity and excellent consistence with conventional nested <jats:styled-content style="fixed-case">RT</jats:styled-content>‐<jats:styled-content style="fixed-case">PCR</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Overall, we believe that this method is easily applicable, cost‐effective, and clinically useful for a rapid screening of fusion genes in the initial diagnostic phase of leukemia. Its use can also be extended to the monitoring of minimal residual disease.</jats:p></jats:sec> |
doi_str_mv | 10.1111/ijlh.12600 |
facet_avail | Online |
finc_class_facet | Medizin, Biologie, Chemie und Pharmazie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9pamxoLjEyNjAw |
imprint | Wiley, 2017 |
imprint_str_mv | Wiley, 2017 |
institution | DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
issn | 1751-5521, 1751-553X |
issn_str_mv | 1751-5521, 1751-553X |
language | English |
last_indexed | 2024-03-01T14:30:01.545Z |
match_str | zheng2017simultaneousdetectionof45fusiongenesinleukemiabydualcolorfluorescencerealtimepcr |
mega_collection | Wiley (CrossRef) |
physical | 175-184 |
publishDate | 2017 |
publishDateSort | 2017 |
publisher | Wiley |
record_format | ai |
recordtype | ai |
series | International Journal of Laboratory Hematology |
source_id | 49 |
spelling | Zheng, Z. Zhang, P. He, G. Liao, K. Wang, Z. Pan, J. Du, K. Du, J. Li, B.‐A. 1751-5521 1751-553X Wiley Biochemistry (medical) Clinical Biochemistry Hematology General Medicine http://dx.doi.org/10.1111/ijlh.12600 <jats:title>Summary</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Detection of recurrent genetic abnormalities is of great significance for a refined diagnosis and assessment of prognosis in leukemia. Conventional nested reverse transcription <jats:styled-content style="fixed-case">PCR</jats:styled-content> is labor intensive and time‐consuming.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We have developed a novel dual‐color TaqMan probe‐based real‐time <jats:styled-content style="fixed-case">PCR</jats:styled-content> method for the simultaneous screening of 45 fusion transcripts in 12 parallel reactions. The method was tested and validated with cell lines carrying known fusion transcripts and patient samples.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A multiplex real‐time <jats:styled-content style="fixed-case">PCR</jats:styled-content> method was successfully developed for rapid detection of 45 fusion genes and validated for 15 of the more commonly detected fusion genes. Intra‐assay reproducibility assessed for the most frequent rearrangements ranged from 0.41% to 0.74% for the coefficient of variation (<jats:styled-content style="fixed-case">CV</jats:styled-content>) of cycle threshold (Ct) and the interassay reproducibility ranged from 1.62% to 2.83% in five separate experiments. The lowest detection limit for the translocations tested ranged between 1 : 16 000 and 1 : 32 000. Validation of the method with 213 patient samples showed 100% specificity and excellent consistence with conventional nested <jats:styled-content style="fixed-case">RT</jats:styled-content>‐<jats:styled-content style="fixed-case">PCR</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Overall, we believe that this method is easily applicable, cost‐effective, and clinically useful for a rapid screening of fusion genes in the initial diagnostic phase of leukemia. Its use can also be extended to the monitoring of minimal residual disease.</jats:p></jats:sec> Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time <scp>PCR</scp> International Journal of Laboratory Hematology |
spellingShingle | Zheng, Z., Zhang, P., He, G., Liao, K., Wang, Z., Pan, J., Du, K., Du, J., Li, B.‐A., International Journal of Laboratory Hematology, Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR, Biochemistry (medical), Clinical Biochemistry, Hematology, General Medicine |
title | Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_full | Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_fullStr | Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_full_unstemmed | Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_short | Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
title_sort | simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time <scp>pcr</scp> |
title_unstemmed | Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR |
topic | Biochemistry (medical), Clinical Biochemistry, Hematology, General Medicine |
url | http://dx.doi.org/10.1111/ijlh.12600 |